Feedback / Questions
CT-0508 - CARISMA Therap
Keytruda (pembrolizumab) - Merck (MSD)
https://www.businesswire.com/news/home/20220921005487/en/Sesen-Bio-and-Carisma-Therapeutics-Announce-Merger-Agreement
Sep 21, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next